Canaan Partners XI LLC holds a concentrated book of 3 stocks worth $127.3M as of Q2 2026 (disclosed Jul 20, 2026, a ~45-day 13F lag). This quarter they opened Rallybio Corp. Their largest long position is Aeva Technologies Inc at 81% of the equity book. Cloning the disclosed picks since 2024 would be +26% (+14.0%/yr). That is a simulation of the disclosed long book, not audited returns.
The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.
This fund page is the Follow view. The Build view lets your agent pull holdings, quarter changes, overlap, and source filings through API or MCP.
curl -H "Authorization: Bearer YOUR_API_KEY" \ "https://arkolith.com/api/v1/funds/1850694/holdings"
Use Arkolith to show Canaan Partners XI LLC's latest holdings, largest changes, and filing provenance.
The reported book (valued from quarter-end) returned +50.0%, a 24.0-point gap that is the cost of the ~45-day 13F disclosure lag a real follower can't avoid.
Growth of $10,000 cloning Canaan Partners XI LLC's disclosed long 13F book, rebalanced on each filing date (so it reflects the ~45-day reporting lag, no look-ahead), total-return basis (dividends reinvested), derived from end-of-day prices. “Their reported book” values the same picks from quarter-end, before they were public. S&P 500 is SPY total return over the same window. Excludes shorts, cash, options and non-13F holdings. Not investment advice.
Top-heavy: concentrated book
Share of the disclosed book in its largest positions. A higher top-5 share means a more concentrated, higher-conviction portfolio.
100% mapped to company sectors
Direct operating-company sectors from our SIC-based security master. ETF/fund and unclassified holdings stay visible separately; this is not ETF look-through exposure.
Bars show each stock's share of the portfolio. Click a row for its position history.
| # | Security | Value | Shares | % Port | Last move | History |
|---|---|---|---|---|---|---|
| 1 | Aeva Technologies Inc COM | $103.3M | 3.60M | 81.2% | —Held | |
| 2 | Tyra Biosciences Inc COM | $24.0M | 750.0K | 18.8% | —Held | |
| 3 | Blink Charging Co COM | $6K | 9.4K | 0.0% | —Held |
As-of date vs the date the SEC received each filing
| Quarter | As of | Filed | Positions | Value | Form |
|---|---|---|---|---|---|
| Q2 2026 | Jun 30, 2026 | Jul 20, 2026 | 3 | $127.3M | 13F-HR |
| Q1 2026 | Mar 31, 2026 | Apr 24, 2026 | 3 | $76.1M | 13F-HR |
| Q4 2025 | Dec 31, 2025 | Feb 13, 2026 | 4 | $136.8M | 13F-HR |
| Q3 2025 | Sep 30, 2025 | Oct 23, 2025 | 3 | $102.9M | 13F-HR |
| Q2 2025 | Jun 30, 2025 | Jul 17, 2025 | 4 | $171.8M | 13F-HR |
| Q1 2025 | Mar 31, 2025 | Apr 9, 2025 | 4 | $66.4M | 13F-HR |
| Q4 2024 | Dec 31, 2024 | Jan 21, 2025 | 3 | $77.3M | 13F-HR |
| Q3 2024 | Sep 30, 2024 | Oct 16, 2024 | 3 | $118.1M | 13F-HR |
Holdings from SEC EDGAR 13F-HR filings, updated quarterly ~45 days after quarter-end. Public domain. The book and weighting are long equity only; disclosed put/call options are listed separately and excluded from those totals. The performance line is a simulation of the disclosed long book, not an audited return.